Georgia's Online Cancer Information Center

USPSTF broadens age range, risk threshold in new recommendation for lung cancer screening

7/16/2020, Georgia CORE

The U.S. Preventive Services Task Force has recommended expanding the eligible age range and broadening the risk threshold for annual low-dose CT screening for lung cancer. A draft published July 7 updates an earlier 2014 guideline by changing the age range for screening from ages 55-80 to 50-80, as well as the risk threshold from 30 pack-years* to 20 pack-years.
 
An active participant in the American Cancer Society’s National Lung Cancer Roundtable, Georgia CORE advocates for increased lung cancer screenings in our state, which has more diagnoses and deaths than the national average. Further, as pointed out in our 5 Actions to Save More Lives report (2020), screening high-risk** Georgians – and there are more than 365,000 of them – would bring more than 14,000 quality-adjusted life years, a measure of disease burden, as well as an economic benefit to our state of over $1 billion.
 
In a recent issue of The Cancer Letter, Michael J. Barry, MD, USPSTF member and medical professor at Harvard Medical School commented: “We can make all the recommendations we want, but unless they’re implemented in practice, we won’t see the expected benefits.”
 
Which is why Georgia CORE has also advocated that more tobacco funds be used for cancer prevention and education. “As we analyzed in 2019, the portion of Georgia’s Tobacco Settlement Funds used to support cancer-related activities is currently around nine cents out of every dollar, even though cancer is the number one health consequence of tobacco use,” said Georgia CORE president and CEO Nancy Paris. “The updated USPSTF recommendations mean that we should be serving an even larger number of high-risk Georgians with screenings and prevention programs. We could save and pro-long more lives by doing so.”
 
*A “pack year” is a clinical measurement of tobacco exposure. A person who has smoked 15 cigarettes a day for 40 years has a 30 pack-year history (15/20 x 40 = 30). 1 pack = 20 cigarettes.
**A Georgia State University analysis considered Georgians ‘high-risk’ if they are aged 55 to 74 who have a smoking history of 30 pack years or greater.

Media, News & Events

New ASCO COVID-19 Registry Aims to Understand Impact on Patients During Pandemic, Inform Future Care

Last week, the American Society of Clinical Oncology (ASCO) launched the ASCO Survey on COVID-19 in Oncology Registry.

 Research 4/20/2020

2021 Atlanta Precision Oncology Symposium

The Atlanta Precision Oncology Symposium (APOS) is designed to present the complexities of oncology precision medicine in an organized, simplified, friendly fashion, so that they can be understood and properly applied to clinical medicine.

Transforming Cancer Care: Developing a Personalized Approach to Survivorship Care

Working and learning about survivorship. 

AstraZeneca acts in accordance with the PhRMA Code on Interactions with Healthcare Professionals. The PhRMA Code states that inclusion of a Healthcare Professional’s spouse or guest at an educational program is not appropriate. Your support of these ethical guidelines will help to ensure a high-quality learning environment for all participating Healthcare Professionals. Thank you.

 Media & Events 10/16/2020

2021 Atlanta Precision Oncology Symposium

This one-day continuing education program will focus on current approaches to integrating and applying precision medicine into managing patients with breast, lung and genitourinary malignancies.

 Media & Events 10/06/2020

Beating Cancer Beautifully

Applications are due by October 5th.

All BCB Beauties (applicants) will be notified October 12th.

 Media & Events 9/30/2020

RACIAL DISPARITIES IN BREAST CANCER SURVIVORSHIP: Engaging a National Healthcare Forum for Change

This virtual forum will address critical disparity in breast cancer outcomes and survivorship in Black women. Georgia CORE is an in-kind sponsor.

 Media & Events 10/20/2020

Georgia CORE and partners win five-year grant for colorectal cancer prevention

The CDC-funded program will bring colorectal screening, navigation and colonoscopies to 15,000 people in southeast and southwest Georgia.

Comparing Community Practice Data in Georgia with the South and U.S.

Georgia CORE's Dr. Hamrick breaks down national data on how COVID-19 has been impacting cancer care in Georgia.

 Media & Events 6/25/2020

How the Georgia Sewers came to the rescue

Nearly 400 volunteers in 58 counties have been cutting out fabric and elastic, handling administrative duties and of course, sewing.

Transforming Cancer Care: Developing a Personalized Approach to Survivorship Care

Working and learning about survivorship. 

AstraZeneca acts in accordance with the PhRMA Code on Interactions with Healthcare Professionals. The PhRMA Code states that inclusion of a Healthcare Professional’s spouse or guest at an educational program is not appropriate. Your support of these ethical guidelines will help to ensure a high-quality learning environment for all participating Healthcare Professionals. Thank you.

 Media & Events 10/16/2020

Subscribe to Our Newsletter

Our email newsletter allows you to get the most up-to-date information right in your Inbox.

Subscribe Now
Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.